Injection, 161Tb-SibuDAB, Dose Escalation: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 1 1

Conditions being studied

Condition	Trials
Castration-resistant Prostate Cancer	1
Prostate cancer	1

Recruiting trials involving Injection, 161Tb-SibuDAB, Dose Escalation

Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b Study
NCT06343038 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Injection, 161Tb-SibuDAB, Dose Escalation?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.